Novartis heads for worst day on record after three drug trial setbacks
Clinical trial outcomes are the sharpest single-session repricing events in large-cap pharma. On Tuesday, three of them moved against Novartis at once, sending shares nearly 10% lower and putting the stock on course for its worst…
By Vincent Lorne · 2 min read
Today's Edition
Latest from the Desk
Liquid white hats return $270 million in Bitcoin as network readies restart
Federated custody security is the live question across Bitcoin's network layer. A group identified as white hats has returned $270 million in Bitcoin to Liquid's federation wallet following a security incident
September 8, 2026 · 2 min
Chainlink breaks from Bitcoin's compression zone, LINK hits eight-month high on institutional deal flow
Crypto's late-summer momentum has stalled at the macro threshold. Bitcoin ($BTC) opened the week below $80,000, down roughly 1% in 24 hours, having been rejected twice from the $82,000 level over the past two weeks and sitting…
September 8, 2026 · 2 min
Hyperliquid Strategies shares surge 94% in August as U.S. regulatory clarity drives crypto treasury premium
The broadening U.S. regulatory posture toward crypto in August 2026 fed directly into the premium that investors were willing to pay for publicly traded digital-asset vehicles. Against that
September 8, 2026 · 2 min
Latest Dispatches
最新報道A standard of reporting the region keeps coming back to.
Clear over clever
文字清晰Plain language and the numbers in context, so a story can be read once and understood.
Independent of the room
獨立持平No proprietor, no party, no platform sets our agenda. Our only obligation is to the reader who needs the call right.
Context with the number
來龍去脈A figure without its history misleads. We put the number next to the forces that produced it.
The Harbour Briefing · 訂閱
The morning read for people who move the region.
One disciplined email at dawn, Hong Kong time. The three stories that matter, the numbers behind them, and the context no wire will give you.